跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19 条关于
“ClonoSEQ”
全部
19
临床试验
5
药物
0
机构
1
资讯
13
9个月前
Adaptive Biotechnologies' clonoSEQ MRD Test Featured in Record 89 Abstracts at ASH 2025
去年
Medicare Expands Coverage of Adaptive Biotechnologies' clonoSEQ for Mantle Cell Lymphoma
去年
Adaptive Biotechnologies Integrates clonoSEQ MRD Testing into Flatiron Health's OncoEMR Platform
前天
NCCN Multiple Myeloma Guidelines Add Dedicated MRD Testing Page, Name clonoSEQ and Set 10-6 as Preferred Sensitivity
去年
Adaptive Biotechnologies Enhances clonoSEQ Assay for DLBCL Minimal Residual Disease Detection with 7-Fold Sensitivity Increase
去年
clonoSEQ Data Show MRD Assessment Impacts Blood Cancer Treatment Decisions
去年
Adaptive Biotechnologies Reports Strong MRD Business Growth in 2024 Financial Results
3个月前
Adaptive Biotechnologies Plans Separation of Immune Medicine Platform, Eyes Strategic Options for Drug Discovery Business
2年前
Telo Genomics Evaluates MRD Assay in Multiple Myeloma with TELO-DMRD Study
2个月前
Telo Genomics Reports Positive Interim Data for 3D Telomere-Based Relapse Risk Assay in Multiple Myeloma
第 1 页,共 2 页
上一页
下一页